Ignite Creation Date:
2025-12-25 @ 12:46 AM
Ignite Modification Date:
2026-01-04 @ 10:23 PM
Study NCT ID:
NCT04383067
Status:
UNKNOWN
Last Update Posted:
2021-02-11
First Post:
2020-05-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2, Single-Center, Open Label Study of Autologous, Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Urothelial Carcinoma Patients
Sponsor:
Sheba Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-12
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-06-01
Completion Date Type:
ESTIMATED
First Submit Date:
2020-05-03
First Submit QC Date:
None
Study First Post Date:
2020-05-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-02-08
Last Update Post Date:
2021-02-11
Last Update Post Date Type:
ACTUAL